Terazosinhydrochloridechemicalstructure (Chemicalstructure)
Terazosin Hydrochloride
Product Images NDC 50090-0659
6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 50090-0659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Figure1)
Two line graphs comparing Terazosin and placebo groups over a 3-month period. The left graph shows mean change in total symptom score from baseline, with Terazosin showing a greater decrease than placebo. The right graph shows mean increase in peak flow rate (mL/sec) from baseline, with Terazosin showing a higher increase than placebo. Sample sizes are indicated for each group.*
Figure2 (Figure2)
A line graph depicting the mean change from baseline over a 30-month period. The x-axis marks months, from 0 to 30, and the y-axis shows the mean change with values ranging from 0 to -7. Data points with asterisks indicate statistical significance for changes at various months. The trend shows a rapid initial decrease followed by a stable decline over time.*
Figure3 (Figure3)
A line chart showing the mean change from baseline in mL/sec over a 30-month period. The x-axis represents time in months, and the y-axis shows the mean change in mL/sec, ranging from 0 to 4.5. Data points include error bars, and several points along the curve are marked with asterisks indicating significance.*
Label Image (Lbl500900659)
Terazosin Hydrochloride 10 mg capsule bottle label from A-S Medication Solutions. The label includes dosage information, storage instructions to keep between 68 to 77 degrees Fahrenheit away from light and moisture, and bottle contents of 90 capsules. The label also shows the NDC number 50090-0659-1 and a QR code for additional drug information.*
Label Image (Lbl500901943)
Terazosin Hydrochloride 5 mg label from A-S Medication Solutions, LLC. The label states the product number (4875-0), lot information, storage instructions to keep the product at 68 to 77 degrees Fahrenheit away from light and moisture, and the package includes 30 capsules. The label indicates the product is equivalent to 5 mg terazosin hydrochloride and is prescription only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
